Experimental study demonstrates a scalable chromatography-free synthesis of diastereopure azabicyclic building blocks, highlighting their potential for isosteric replacement in drug design.
A convenient approach to the synthesis of diastereopure 6‐ and 2,6‐substituted 2‐azabicyclo[3.2.0]hexanes is reported. The method is based on the sequential construction of the cyclobutane and pyrrolidine rings of the target bicyclic system via [2+2] ketene cycloaddition and lactam formation, respectively. Although the key cycloaddition step had modest stereoselectivity ( dr 2:1), the target bicyclic product could be obtained as a pure diastereomer without using chromatographic purification. The reaction sequence commences from readily available starting materials and is easily scalable (up to 32.8 g). Utility of the synthesized intermediates is demonstrated by the preparation of a series of exo ‐ and endo ‐isomeric amino alcohols and monoprotected diamines—valuable building blocks for drug discovery. Their potential for isosteric replacements is evaluated by measuring physicochemical properties, as well as structural studies and exit vector plot analysis.
No takes yet. Share an insight, caveat, or question.
Nosyk et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: